Bristol-Myers Squibb announces U.S. FDA approval of an additional indication for Opdivo (nivolumab)
5 March 2015 | By Bristol-Myers Squibb
Bristol-Myers Squibb Company announced an approval of an additional indication for Opdivo (nivolumab) by the U.S. Food and Drug Administration...